Quel est l'impact des complications sur le séjour ?
Les complications peuvent prolonger le séjour hospitalier et augmenter les coûts de soins.
Séjour hospitalierCoûts de soins
Facteurs de risque
5
#1
Quels facteurs de risque influencent l'hospitalisation ?
Des facteurs comme l'âge, les comorbidités et le mode de vie augmentent le risque.
ComorbiditésMode de vie
#2
Comment les antécédents médicaux affectent-ils le séjour ?
Les antécédents médicaux peuvent influencer le traitement et le risque de complications.
Antécédents médicauxRisque de complications
#3
Quel rôle joue l'environnement dans le risque d'infection ?
Un environnement non stérile augmente le risque d'infections nosocomiales.
Environnement hospitalierInfections nosocomiales
#4
Comment le stress affecte-t-il la santé en chambre ?
Le stress peut aggraver les symptômes et retarder la guérison des patients.
StressGuérison
#5
Quels comportements augmentent le risque de complications ?
Des comportements comme le tabagisme et la sédentarité augmentent le risque de complications.
TabagismeSédentarité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chambre de patient : Questions médicales les plus fréquentes",
"headline": "Chambre de patient : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chambre de patient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-14",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chambre de patient"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Établissements de santé",
"url": "https://questionsmedicales.fr/mesh/D006268",
"about": {
"@type": "MedicalCondition",
"name": "Établissements de santé",
"code": {
"@type": "MedicalCode",
"code": "D006268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.278"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chambre de patient",
"alternateName": "Patients' Rooms",
"code": {
"@type": "MedicalCode",
"code": "D010362",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Erwin Ista",
"url": "https://questionsmedicales.fr/author/Erwin%20Ista",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, section Nursing Science, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Monique van Dijk",
"url": "https://questionsmedicales.fr/author/Monique%20van%20Dijk",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, section Nursing Science, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands."
}
},
{
"@type": "Person",
"name": "Melinda Wang",
"url": "https://questionsmedicales.fr/author/Melinda%20Wang",
"affiliation": {
"@type": "Organization",
"name": "From the Yale School of Medicine."
}
},
{
"@type": "Person",
"name": "Barbara Banda",
"url": "https://questionsmedicales.fr/author/Barbara%20Banda",
"affiliation": {
"@type": "Organization",
"name": "VA Connecticut Healthcare System, West Haven, Connecticut."
}
},
{
"@type": "Person",
"name": "Naseema B Merchant",
"url": "https://questionsmedicales.fr/author/Naseema%20B%20Merchant",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents.",
"datePublished": "2024-09-05",
"url": "https://questionsmedicales.fr/article/39275060",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules29174213"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel C19ORF12 mutation in two MPAN sisters treated with deferiprone.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37004026",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-023-03172-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deferiprone-gallium-protoporphyrin (IX): A promising treatment modality against Mycobacterium abscessus.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37506532",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tube.2023.102390"
}
},
{
"@type": "ScholarlyArticle",
"name": "No difference in myocardial iron concentration and serum ferritin with deferasirox and deferiprone in pediatric patients with hemoglobinopathies: A systematic review and meta-analysis.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35878782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tracli.2022.07.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35743183",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms23126735"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Établissements de santé",
"item": "https://questionsmedicales.fr/mesh/D006268"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chambre de patient",
"item": "https://questionsmedicales.fr/mesh/D010362"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chambre de patient - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chambre de patient",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chambre de patient",
"description": "Comment évaluer l'état d'un patient en chambre ?\nQuels outils sont utilisés pour le diagnostic en chambre ?\nComment surveiller un patient en chambre ?\nQuelles sont les méthodes de diagnostic en chambre ?\nQuel rôle joue l'infirmière dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chambre de patient",
"description": "Quels symptômes peuvent nécessiter une hospitalisation ?\nComment les symptômes sont-ils surveillés en chambre ?\nQuels symptômes indiquent une détérioration ?\nComment signaler des symptômes nouveaux ?\nQuels symptômes nécessitent une intervention rapide ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chambre de patient",
"description": "Comment prévenir les infections en chambre ?\nQuelles sont les pratiques de prévention des chutes ?\nComment prévenir les escarres en chambre ?\nQuel rôle joue l'éducation des patients dans la prévention ?\nComment prévenir les erreurs médicamenteuses ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chambre de patient",
"description": "Quels traitements sont administrés en chambre ?\nComment les traitements sont-ils ajustés ?\nQuel est le rôle des protocoles de traitement ?\nComment les effets secondaires des traitements sont-ils gérés ?\nQuels traitements sont courants pour les infections ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chambre de patient",
"description": "Quelles complications peuvent survenir en chambre ?\nComment gérer les complications en chambre ?\nQuels signes indiquent une complication ?\nComment prévenir les complications post-opératoires ?\nQuel est l'impact des complications sur le séjour ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chambre de patient",
"description": "Quels facteurs de risque influencent l'hospitalisation ?\nComment les antécédents médicaux affectent-ils le séjour ?\nQuel rôle joue l'environnement dans le risque d'infection ?\nComment le stress affecte-t-il la santé en chambre ?\nQuels comportements augmentent le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D010362?mesh_terms=Deferiprone#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'état d'un patient en chambre ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des examens cliniques et des tests diagnostiques."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en chambre ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des appareils comme les moniteurs de signes vitaux et les échographes sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment surveiller un patient en chambre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut le suivi des paramètres vitaux et l'observation des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles sont les méthodes de diagnostic en chambre ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les méthodes incluent l'imagerie, les analyses de sang et les examens physiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'infirmière dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infirmière collecte des données et aide à interpréter les résultats des tests."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter une hospitalisation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme la douleur intense, la fièvre élevée ou la confusion."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils surveillés en chambre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont surveillés par des évaluations régulières et des rapports d'infirmières."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une détérioration ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une détérioration peut se manifester par une aggravation de la douleur ou des signes vitaux anormaux."
}
},
{
"@type": "Question",
"name": "Comment signaler des symptômes nouveaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent informer le personnel soignant immédiatement de tout changement."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une intervention rapide ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'essoufflement ou la perte de conscience nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections en chambre ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures d'hygiène strictes et l'utilisation d'équipements de protection sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles sont les pratiques de prévention des chutes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pratiques incluent l'évaluation des risques et l'utilisation de dispositifs d'assistance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les escarres en chambre ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le repositionnement régulier et l'utilisation de matelas spéciaux aident à prévenir les escarres."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation des patients dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation aide les patients à comprendre les risques et à participer activement à leur soin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les erreurs médicamenteuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vérifications systématiques et des protocoles de double vérification sont mis en place."
}
},
{
"@type": "Question",
"name": "Quels traitements sont administrés en chambre ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des perfusions et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils ajustés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements sont ajustés en fonction de la réponse du patient et des résultats des tests."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des protocoles de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les protocoles guident les soins et assurent la cohérence dans l'administration des traitements."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires des traitements sont-ils gérés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires sont surveillés et gérés par des ajustements de dosage ou des médicaments supplémentaires."
}
},
{
"@type": "Question",
"name": "Quels traitements sont courants pour les infections ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections sont souvent traitées avec des antibiotiques et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en chambre ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les infections, les thromboses et les réactions aux médicaments."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications en chambre ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion implique une surveillance étroite et des interventions médicales appropriées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une douleur accrue, une fièvre persistante ou des changements de comportement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-opératoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des soins appropriés, une surveillance et une mobilisation précoce."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des complications sur le séjour ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent prolonger le séjour hospitalier et augmenter les coûts de soins."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent l'hospitalisation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, les comorbidités et le mode de vie augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux affectent-ils le séjour ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux peuvent influencer le traitement et le risque de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement dans le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement non stérile augmente le risque d'infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la santé en chambre ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les symptômes et retarder la guérison des patients."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des comportements comme le tabagisme et la sédentarité augmentent le risque de complications."
}
}
]
}
]
}
Department of Anesthesiology and Perioperative Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Anesthesiology, University of Colorado, Anschutz School of Medicine, Aurora, Colorado.
Departments of Anesthesiology, Orthopaedics and Rehabilitation, and Surgery, Larner College of Medicine, University of Vermont, Burlington, Vermont, USA.
The accumulation of iron in dopaminergic neurons can cause oxidative stress and dopaminergic neuron degeneration. Iron chelation therapy may reduce dopaminergic neurodegeneration, but chelators should...
Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare and devastating disease caused by pathogenic mutations in C19orf12 gene. MPAN is characterized by pathological iron accumul...
We reported that two sisters from the same family diagnosed with MPAN had dramatically different responses to deferiprone (DFP) treatment. The diagnosis of MPAN were established based on typical clini...
The findings of this study enriched the MPAN gene database and indicated that DFP might ameliorate symptom progression in patients without severe autonomic neuropsychiatric impairment at the early sta...
Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD) caused by Mycobacterium abscessus is a frequent complication in patients with cystic fibrosis (CF) that worsens lung function over time. Curren...
Iron overload is a common complication experienced by transfusion-dependent children with hemoglobin disorders. Chelators such as deferasirox (DFX) and deferiprone (DFP) are effective in overcoming th...
PubMed and Cochrane Central were searched from their inception until Dec 21 2021, for randomized clinical trials (RCTs) and observational studies, which assessed the efficacy of DFX compared to DFP in...
A total of 5 studies comprising 607 children were included. The results of our analysis revealed no significant difference between DFX and DFP in MRI T2* at the end of treatment (WMD: -0.92; 95% CI [-...
Our analysis shows no significant difference between the efficacy of DFX and DFP in the management of iron overload in children with inherited blood disorders. Future large-scale clinical trials are r...
The need for preparing new strategies for the design of emergency drug therapies against COVID-19 and similar diseases in the future is rather urgent, considering the high rate of morbidity and especi...
In the absence of YFH1, the yeast ortholog of the human FXN gene, budding yeast Saccharomyces cerevisiae experience similar problems to those of cells with Friedreich's ataxia (FRDA). The comparable p...
Deferiprone (DFP) is an oral iron-chelating agent that is widely used in thalassemia patients with iron overload. This study aimed to investigate the long-term efficacy of DFP monotherapy on serum fer...
The historical insights and background of the discovery, development and clinical use of deferiprone (L1) and the maltol-iron complex, which were discovered over 40 years ago, highlight the difficulti...
Children with sickle cell disease (SCD) who are chronically transfused often, require iron chelation therapy. There are limited data that allow for comparison of the efficacy and safety of the iron ch...
This post hoc analysis of the phase 3b/4, randomized, open-label FIRST (Ferriprox in Patients with IRon Overload in Sickle Cell Disease Trial) study (NCT02041299) included patients 17 years and younge...
Overall, 142 patients were evaluated; mean ages were 10.5 and 11.7 years in the deferiprone and deferoxamine groups, respectively. At 12 months: mean change from baseline in liver iron concentration w...
This post hoc analysis of pediatric patients from FIRST corroborated previous findings in adults that deferiprone is comparable to deferoxamine in reducing iron overload. No new safety concerns were o...
A 56-year-old Thai male, known for allergies to penicillin, sulfa, and lincosamide, presented with hyperferritinemia. Upon initiating deferiprone therapy, the patient experienced recurrent episodes of...